This translates into decrease of cerebral edema and brain swelling, possibly through reduction of matrix metalloproteinases-2 and -9 (Kim et al., 2008), which are associated with BBB disruption and could thus offer another possible therapeutic approach in treatment of brain edema (Kim et al., 2010). Here, MMP2 is linked to brain edema.